Pictet Asset Management Holding Sa Crinetics Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 908,149 shares of CRNX stock, worth $49 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
908,149
Previous 300,868
201.84%
Holding current value
$49 Million
Previous $13.5 Million
244.25%
% of portfolio
0.05%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CRNX
# of Institutions
241Shares Held
79.5MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$336 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$318 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$267 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$241 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.9B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...